Redmile Group, LLC Cytokinetics Inc Transaction History
Redmile Group, LLC
- $1.53 Billion
- Q2 2024
A detailed history of Redmile Group, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Redmile Group, LLC holds 111,867 shares of CYTK stock, worth $5.8 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
111,867
Previous 161,600
30.78%
Holding current value
$5.8 Million
Previous $11.3 Million
46.51%
% of portfolio
0.4%
Previous 0.45%
Shares
2 transactions
Others Institutions Holding CYTK
# of Institutions
408Shares Held
126MCall Options Held
3.29MPut Options Held
2.01M-
Black Rock Inc. New York, NY14.7MShares$760 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$593 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.14MShares$422 Million0.28% of portfolio
-
Wellington Management Group LLP Boston, MA7.51MShares$389 Million0.07% of portfolio
-
State Street Corp Boston, MA6.55MShares$339 Million0.02% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.88B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...